The importance of chronic disease co-morbidity in terms of the impact of COVID-19 infection is a major learning from the pandemic, which has highlighted the need to escalate the battle against NCDs, not just for its own sake, but to build resilience and reduce the impact of this and future infectious disease outbreaks.
The George Institute is working on a series of analyses and outputs to highlight different aspects of the intersection of the pandemic with NCDs; the importance and impact of COVID-19 on NCD prevention and management in different contexts; and key research questions and innovation opportunities emerging as a consequence.
